Navigation Links
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
Date:5/15/2008

/20 mg), 6.2% (5/40 mg), 13.3% (10/20 mg), and 11.2% (10/40 mg). The edema incidence for placebo was 12.3%.

Adverse reactions seen at lower rates but at about the same or greater incidence as in patients receiving placebo included hypotension, orthostatic hypotension, rash, pruritus, palpitation, urinary frequency, and nocturia.

In individual clinical trials of amlodipine and olmesartan medoxomil, other commonly reported adverse reactions included headache, dizziness, and flushing.

For more information on AZOR, call 877-4-DSPROD (877-437-7763) or go to the web site http://www.azor.com.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world. The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders.

For more information, please visit http://www.dsus.com.

* SeDBP = Seated Diastolic Blood Pressure. According to the JNC 7, a

SeDBP between 90 and 99 is considered stage 1 hypertension and 100

and above is considered stage 2 hypertension.

(1) Ong KL, et al. Prevalence, awareness, treatment and control of

hypertension among United States Adults 1999-2004. Hypertens 2007;

49: 69-75

(2) Margolis et al. Blood Pressure Control
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
5. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
6. Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
7. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
8. CV Therapeutics Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
9. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
10. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013  TNI BioTech, Inc. (OTCQB: TNIB), ... and mobilization of the body,s immune system using patented immunotherapy, ... Markets, OTCQB marketplace under the ticker symbol "TNIB" commencing ... real-time Level II stock quotes for TNIB at ... , CEO of TNI BioTech, Inc. stated, "We are ...
(Date:5/20/2013)...  Medicare Part D seniors in plans with ... costs, convenient access to pharmacies and other benefits, ... Associates released today by the Pharmaceutical Care Management ... seniors (9.5 million) are currently enrolled in plans ... lower costs, pharmacy choices, and overall value of ...
(Date:5/20/2013)... 2013 With herbal medicines relied upon by ... U.S. Pharmacopeial Convention (USP) will provide freely available public ... ingredients used in these products. Today, USP proposes the ... Herbal Medicines Compendium ( HMC ) for ... hmc.usp.org . HMC will provide standards ...
Breaking Medicine Technology:TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
... Data Showed Clinically Meaningful Benefits for Patients ... LONDON, May 29 ,GlaxoSmithKline (GSK) today announced ... the U.S. Food and Drug Administration and ... Rezonic(TM)/Zunrisa(TM) (casopitant), a novel,investigational NK-1 receptor antagonist. ...
... Phase III Studies With Ofatumumab, Zalutumumab and Zanolimumab, ... (OMX:,GEN) reports today that the last patient to ... in the pivotal Phase III clinical trial,of ofatumumab ... received the last scheduled treatment., In order ...
Cached Medicine Technology:GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 2GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 3GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 4GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 5GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 6GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 7GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 8Genmab Announces Updates on Phase III Cancer Studies 2Genmab Announces Updates on Phase III Cancer Studies 3
(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 Soliant ... Adecco Group, has opened up voting for its fifth annual ... wealth of great nominations this year, Soliant decided to bypass ... 50 entries, but all entries received to be in the ... The voting period begins on May 20 and runs through ...
(Date:5/20/2013)... May 20, 2013 Jointly ... (PolyU) and Sichuan University (Sichuan U), China's ... (IDMR) has recently been officially opened. Both ... Revival and International Disaster Reduction" to conclude ... Lushan 4.20 Earthquake. Ms Margareta Wahlström, Special ...
(Date:5/20/2013)... Brenda Goodman HealthDay Reporter , , SATURDAY, May ... doctors a better view during colonoscopies may help them ... study shows. Colonoscopies are the recommended screening tests ... killer of men and women in the United States. ... flexible tube with a camera mounted on the end ...
(Date:5/20/2013)... with inflammatory bowel disease (IBD) are at higher risk ... at Mayo Clinic. Researchers found that IBD is associated ... The findings were presented at the Digestive Disease Week ... million Americans have Crohn,s disease or ulcerative colitis (UC), ... conditions inflame the lining of the intestine, leading to ...
(Date:5/20/2013)... 2013 ParentMagic, the creator of the best ... off the entire store in the month of May 2013. ... teachers, parents of adolescents and anyone interested in learning more ... books and other written materials, ParentMagic offers DVDs and Audio ... complement both the parent and teacher editions. , Parents who ...
Breaking Medicine News(10 mins):Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 2Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 3Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 4Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 5Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 6Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 7Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 8Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 9Health News:PolyU and Sichuan U Jointly Set Up China's First Institute for Disaster Management and Reconstruction 2Health News:PolyU and Sichuan U Jointly Set Up China's First Institute for Disaster Management and Reconstruction 3Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:ParentMagic Announces May Sale, 20% Off Entire Catalog of Best Selling Books 2
... , , ARLINGTON, ... Health and Human Services Office of Inspector General (OIG) ignored ... including complex rehab, to seniors and people with disabilities who ... the Medicare Program: Supplier Acquisition Costs and Services" and dated ...
... OKLAHOMA CITY, Sept. 3 Surgical Hospital of ... partnered with Surgical Care Affiliates (SCA), one of the country,s ... is a state of the art hospital providing surgical services ... pain management, podiatry and orthopedics. SCA and a number of ...
... done to protect young knees, ankles and shoulders, researcher says ... all high school sports injuries are bad enough to keep a ... the pack in severe injuries, a new U.S. study finds. , ... girls experienced a greater rate of severe injury than boys in ...
... worldunderstand and prepare for contagious outbreaks, the National Institutes ... adds new research expertise to increase its capacity to ... inform public health officials and policymakers. In ... and infected people around the world. In 2003, a ...
... delaying needed care ends up raising health-care costs, study ... -- Patients who don,t trust the health-care system are ... health and raising overall health care costs, a new ... majority of whom were black, about their attitudes toward ...
... , , , , ... entered into a definitive agreement under which Embla will acquire Covidien,s ... the Sandman(TM) brand name. Financial terms of the transaction were ... conditions. , , The combined entity will form ...
Cached Medicine News:Health News:Federal Study on Power Wheelchair Costs in Medicare Is Misleading and Ignores Costs of Required Services for Beneficiaries 2Health News:Federal Study on Power Wheelchair Costs in Medicare Is Misleading and Ignores Costs of Required Services for Beneficiaries 3Health News:Surgical Hospital of Oklahoma to Partner with Surgical Care Affiliates 2Health News:High School Sports Put Players at Risk for Severe Injuries 2Health News:New grants expand US infectious disease modeling effort 2Health News:New grants expand US infectious disease modeling effort 3Health News:Mistrust May Cause People to Put Off Treatment 2Health News:Embla(R) Systems Announces the Acquisition of the Sandman(R) Sleep Diagnostic Business from Covidien(R) - Creating the World's Largest Sleep Diagnostic Company 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: